Bolden Therapeutics

About:

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.

Website: https://www.boldentherapeutics.com/

Top Investors: National Institute on Aging, Partners Resolute, Lifespan Vision Ventures

Description:

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.

Total Funding Amount:

$2.6M

Headquarters Location:

Providence, Rhode Island, United States

Founded Date:

2019-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-01-09

IPO Status:

Private

Industries: